CS logo
small CS logo
Chu Estaing de Clermont-Ferrand

Clermont Ferrand, France
Centre hospitalier universitaire à Clermont-Ferrand

About Chu Estaing de Clermont-Ferrand


L'hôpital d'Estaing ou CHU Estaing est un hôpital situé à Clermont-Ferrand, dans le Puy-de-Dôme. Il fait partie du CHU de Clermont-Ferrand.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Chu Estaing de Clermont-Ferrand


During the past decade, Chu Estaing de Clermont-Ferrand conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Chu Estaing de Clermont-Ferrand" #1 collaborator was "Pierre Fabre Medicament" with 2 trials as a collaborator, "Accord Healthcare, Inc." with 1 trials as a collaborator, "Belgian Group of Digestive Oncology" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "Cancer Research UK & UCL Cancer Trials Centre" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

Clinical Trials Conditions at Chu Estaing de Clermont-Ferrand


According to Clinical.Site data, the most researched conditions in "Chu Estaing de Clermont-Ferrand" are "BRAF V600E Mutation Positive" (1 trials), "Biliary Tract Neoplasms" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Chu Estaing de Clermont-Ferrand" in a lesser frequency.

Clinical Trials Intervention Types at Chu Estaing de Clermont-Ferrand


Most popular intervention types in "Chu Estaing de Clermont-Ferrand" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Binimetinib" (1 trials), "Cisplatin" (1 trials), "Collection of blood samples" (1 trials), "Encorafenib" (1 trials) and "Futibatinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Chu Estaing de Clermont-Ferrand


The vast majority of trials in "Chu Estaing de Clermont-Ferrand" are 2 trials for "All" genders.

Clinical Trials Status at Chu Estaing de Clermont-Ferrand


Currently, there are NaN active trials in "Chu Estaing de Clermont-Ferrand". 2 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Chu Estaing de Clermont-Ferrand, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chu Estaing de Clermont-Ferrand, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".